ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 270 filers reported holding ALKERMES PLC in Q2 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $249,000 | +5.5% | 4,250 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $236,000 | +0.4% | 4,250 | -15.0% | 0.01% | 0.0% |
| Q3 2016 | $235,000 | -5.6% | 5,000 | -13.0% | 0.01% | 0.0% |
| Q2 2016 | $249,000 | +12.2% | 5,750 | -11.5% | 0.01% | +11.1% |
| Q1 2016 | $222,000 | -57.0% | 6,500 | 0.0% | 0.01% | -55.0% |
| Q4 2015 | $516,000 | +35.4% | 6,500 | 0.0% | 0.02% | +33.3% |
| Q3 2015 | $381,000 | -8.9% | 6,500 | 0.0% | 0.02% | +7.1% |
| Q2 2015 | $418,000 | +5.6% | 6,500 | 0.0% | 0.01% | +7.7% |
| Q1 2015 | $396,000 | -20.5% | 6,500 | -23.5% | 0.01% | -18.8% |
| Q4 2014 | $498,000 | – | 8,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |